ATP. a pioneer in life sciences venture capital, is developing the next generation of transformative biotechnology companies.

We create science-based companies starting with assets at various stages: from working with scientists on pre-IP ideas, to spinouts from existing company pipelines.

We provide flexible capital, strategic insight, and operational resources to build sustainable, research-driven enterprises.

We invest in our companies from seed stage through IPO and beyond, and we support our management teams in strategic transactions and synergistic business combinations.